All News Balaxi Pharmaceuticals Limited

Equities

BALAXI

INE618N01022

Market Closed - NSE India S.E. Other stock markets 12:43:53 14/06/2024 BST			5-day change	1st Jan Change
120.9 ^INR	-2.56%		+6.41%	+39.86%

05-29	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
05-09	Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-29	CI
Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer	05-09	CI
Balaxi Pharmaceuticals Limited Announces Resignation of Purnima Singh Kamble as Independent Director	05-08	CI
Balaxi Pharmaceuticals Limited Announces Resignation of Udayan Shukla as Company Secretary and Compliance Officer	05-04	CI
Balaxi Pharmaceuticals Limited Incorporates New Wholly Owned Subsidiary in Chile	02-14	CI
Balaxi Pharmaceuticals Limited Announces Update on Company's Pharmaceutical Formulation Plant	02-09	CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-09	CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-02	CI
Balaxi Pharmaceuticals Limited completed the acquisition of Balaxi Healthcare Ecuador S.A.S.	30/09/23	CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	03/08/23	CI
Balaxi Pharmaceuticals Limited agreed to acquire Balaxi Healthcare Ecuador S.A.S. for $0.04 million.	02/08/23	CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/05/23	CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	01/02/23	CI
Balaxi Pharmaceuticals : Certificate under SEBI (Depositories and Participants) Regulations, 2018	10/01/23	PU
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	05/11/22	CI
Balaxi Pharmaceuticals : Press Release	05/09/22	PU
Balaxi Pharmaceuticals : Extra Ordinary Meeting	05/09/22	PU
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	02/08/22	CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	23/05/22	CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	09/02/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Balaxi Pharmaceuticals Limited

Equities

BALAXI

INE618N01022

All News

Filters